Ultragenyx DTX301 Gene Therapy Update
Update on DTX301 Gene Therapy Clinical Study for Ornithine Transcarbamylase (OTC) Deficiency Nine people with OTC deficiency are enrolled & have received gene therapy at 3 different dose levels in
July 9, 2020